1. Industries
  2. Healthcare & life sciences
  3. Clinical Research & Trials
Clinical research & trials

Every study, every site, one view —
without rebuilding the report each week.

TURBOARD brings EDC, CTMS, laboratory and safety data into one governed model, so CROs, sponsors and research sites follow enrolment, safety and data quality across the whole portfolio.

Trial data is collected carefully — and reported by hand.

Laboratory equipment, sample tubes and study records connected to one analytics view.

A running trial produces data in the EDC, the CTMS, central laboratory files, safety databases and site spreadsheets. Medical monitors, sponsors, steering committees and investors each need their own report, so study teams spend days every cycle exporting, cleaning and reformatting the same data. By the time a slow site or a rising screen-failure rate is visible, weeks of enrolment have been lost.

TURBOARD connects these sources once and calculates enrolment, visit compliance, adverse events and data quality the same way for every study. Each stakeholder sees a dashboard limited to the studies and sites they are entitled to, and recurring reports are distributed automatically. Study teams review the data instead of assembling it.

500K+business users work with TURBOARD
Since 2004enterprise BI engineering, founded in Chicago
Cloud or on-premisefully on-premise deployment, AI included
PatentedBI technology, including a granted US patent
What you can do

Study analytics from the same governed model

01

Enrolment and recruitment

Screened, randomised and active subjects against plan by study, country and site, with screen-failure and dropout rates and their reasons.

02

Site performance

Enrolment speed, visit compliance and open data queries per site, compared side by side so under-performing sites are visible early.

03

Safety overview

Adverse events by severity, seriousness, status, study arm and dose, with drill-down from the portfolio to the individual subject.

04

Visits and laboratory results

Visit counts and dates across trial periods, lab values by arm and gender, and outlier analysis on rating-scale outcomes.

05

Portfolio view

All studies on one screen — status, milestones, enrolment and safety — to support go, adjust or stop decisions.

06

Trial landscape

Public trial registry data analysed by therapeutic area, phase, sponsor and outcome, for protocol planning and competitive context.

Challenges & solutions

Where trial reporting gets stuck — and how TURBOARD helps

?Manual, repeated reporting

Reports for monitors, sponsors and committees are rebuilt in spreadsheets every cycle.

✓Scheduled, consistent reports

Dashboards refresh with the data and scheduled reports go to each stakeholder as PDF, Excel or PowerPoint.

?Standalone tools

EDC, CTMS, lab and safety systems each hold part of the picture, and nobody sees the whole study.

✓One connected model

Sources are joined over shared dimensions such as study, site and subject, so every metric is calculated the same way.

?Each party needs a different view

Sponsors, CRO teams and sites must see only their own studies and subjects, which multiplies report versions.

✓Row-level permissions

One dashboard serves everyone; every user and every scheduled report sees only authorised data.

?Problems surface late

Slow recruitment, missing visits or rising adverse events appear only in the next periodic report.

✓Thresholds made visible

Conditional formatting marks sites and metrics that cross their limits as soon as the data refreshes.

JAS · Just Ask Simply

Ask about a study in plain language

JAS, the AI assistant built into TURBOARD, answers from the same governed study model your dashboards use. She finds the relevant report or writes the query, builds the chart and explains what changed. With JAS Explain and personas, a medical monitor and a sponsor executive each get an interpretation that fits their role, from identical numbers.

Explore JAS capabilities →
JJASQuestions you can ask
  • Which sites are furthest behind their enrolment target this month?
  • Show the screen-failure rate by country and main reason for study 204.
  • List serious adverse events by study arm and dose level for the last quarter.
  • Compare visit compliance across our oncology studies with the same period last year.

See your whole study portfolio on one screen.

We will connect a sample of your study data and show how TURBOARD and JAS track enrolment, sites and safety across trials.

Are you curious?